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urothelial carcinomaBackground/Purpose: Cigarette smoking, exposure to secondhand smoke, and arsenic expo-
sure are well known risk factors for developing urothelial carcinoma (UC). We investigated
the combined effects of cigarette smoking, exposure to secondhand smoke, and the presence
of urinary total arsenic on the risk of developing UC.
Methods: We conducted a hospital-based, caseecontrol study involving 261 UC patients and
672 cancer-free control individuals between September 2002 and May 2009.
Results: Individuals who had smoked <100 cigarettes in their lifetime (never smokers) and had
a high urinary total arsenic level (15.40 mg/g creatinine), and those who had smoked >100
cigarettes in their lifetime (ever smokers) and had a high urinary total arsenic level, had
increased risks of developing UC (3.20-fold and 6.45-fold greater), respectively, compared
to individuals who were never smokers and had a low urinary total arsenic level. Individuals
who had high urinary total arsenic levels and had been exposed to secondhand smoke, and in-
dividuals with high urinary arsenic levels who had not been exposed to secondhand smoke, had
increased chances (2.71-fold and 5.00-fold greater, respectively) of developing UC, compared
to individuals who were not exposed to secondhand smoke and had low urinary total arsenic
levels. Ever smokers who had been exposed to secondhand smoke and had a high urinary total
arsenic level had the greatest increased risk for developing UC (10.82-fold greater).
Conclusion: Individuals in a Taiwanese population who smoked cigarettes, were exposed to
secondhand smoke, and a high urinary total arsenic level, had a significant risk for developing UC.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
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Urothelial carcinoma (UC) includes cancers of the ureter,
renal pelvis, and bladder. The most common site for UC is
the bladder. Bladder cancer is a multifactorial malignancy
influenced by environmental risk factors and molecular
variations in genes related to metabolism.1 Several risk
factors are known for UC, including occupational exposure
to chemicals or Chinese herbs,2 cigarette smoking, coffee
drinking, ingestion of analgesics or artificial sweeteners,
and receiving genotoxic chemotherapeutic agents. Based
on the causal effect and frequency of UC-related risk fac-
tors, cigarette smoking is the major factor.3,4 Cigarettes
contain about 55 chemical carcinogens that are associated
with the development of bladder cancer.5 Environmental
tobacco smoke (secondhand smoke) contains several
chemical carcinogens and is thought to be associated with
bladder cancer.6,7 Chronic arsenic exposure produced by
drinking well water, occupational exposure to hazardous
carcinogenic chemicals, and inflammation are known to be
additional risk factors for developing bladder cancer.8,9
Many epidemiological studies4,10 have reported that ciga-
rette smokers have a high risk for developing bladder cancer.
Our previous study indicated that cigarette smokers have a
significantly higher risk of developing UC than individuals who
have never smoked.11 Moreover, a significant doseeresponse
relationship between chronic exposure to inorganic arsenic
from drinking artesianwell water and the incidence of bladder
cancer has been reported in our previous studies.12,13
Inorganic arsenic is usually found in drinking water in the
formof arsenate (AsV) or arsenite (AsIII).14 In humans, inorganic
arsenic is biotransformed as follows: AsV/ AsIII/ monome-
thylarsonic acid (MMAV) / monomethylar-sonous acid
(MMAIII)/ dimethylarsinic acid (DMAV). MMAIII and dimethy-
larsonous acid (DMAIII) are more toxic15 than inorganic arsenic.
Therefore, inhumans,when theprocessofarsenicmethylation
is inefficient, toxic MMAIII cannot be subsequently methylatedto form DMAV. In other words, when exposure to arsenic in-
creases, the percentage of urinary MMAV increases, whereas
the percentage of DMAV decreases; this indicates an inefficient
methylation process. However, in humans, DMAV is seldom
transformed to DMAIII. In addition, the ability to metabolize
inorganic arsenic differs among individuals. Therefore, a defi-
cient biotransformation of inorganic arsenic may modify the
susceptibility of an individual to developing UC.
The interaction between arsenic exposure and cigarette
smoking has been reported in previous studies.16e17 Our
previous study also found that cigarette smoking can
interact with various forms of urinary arsenic and further
modify the risk for developing UC.11 In addition, another
study proposed that relationships exist between exposure
to secondhand smoke, arsenic methylation capability, and
the development of bladder cancer.18 Moreover, cigarette
smoking, secondhand smoke, and arsenic exposure have
been found to generate oxidative stress and trigger
inflammation.19e21 Chronic inflammation has been shown to
be a risk factor for developing bladder cancer.22,23
Although the interaction between arsenic exposure and
cigarette smoking has been identified, the combined effects
of cigarette smoking, exposure to secondhand smoke, and
urinary arsenic levels on the risk for developing UC remain
unknown. Therefore, we conducted a hospital-based,
caseecontrol study to address this issue. Furthermore, we
examined the combined effects of cigarette smoking,
exposure to secondhand smoke, and urinary total arsenic
levels on the development of UC in a Taiwanese population.
Materials and methods
Study population
This study enrolled 933 participants from the Department
of Urology, National Taiwan University Hospital, between
September 2002 and May 2009. A total of 261 patients with
556 C.-C. Wu et al.UC (mean age 63.27  13.86 years) and 672 cancer-free
control individuals (mean age 56.70  13.72 years) were
recruited from a hospital-based pool, including those who
received a health examination at Taipei Medical University
Hospital or at Taipei Municipal Wan Fang Hospital. The
three hospitals are all located in Taipei city and are clas-
sified as tertiary referral centers. Therefore, few differ-
ences would be expected regarding the source of patients
and the medical residents performing health examinations
at the three hospitals. UC cases were identified by histo-
pathological confirmation conducted by the Department of
Urology, National Taiwan University Hospital. The surgical
specimens were obtained by either endoscopic resection of
the bladder tumors or radical cystectomy. Patients with
metastatic UC and those who had other malignancies were
excluded. Control individuals were selected from those
who were admitted to the collaborating hospitals for a
general health examination, and had no history of cancer
or urological diseases (e.g., urolithiasis, urinary tract
infection, or benign prostatic hyperplasia). We attempted
to enroll UC cases and controls in a ratio of 1:2; however,
some UC patients were excluded due to the presence of
other concurrent malignancies, or incomplete collection of
biological specimens. Finally, 261 UC patients and 672
control individuals entered the study. All participants
provided signed informed consent at the time of being
interviewed and then donated biological specimens. The
Research Ethics Committee of the National Taiwan Uni-
versity Hospital, Taipei Medical University Hospital, and
Taipei Municipal Wan Fang Hospital approved the study,
which also complied with the World Medical Association
Declaration of Helsinki.Table 1 Demographic characteristic of UC patients and non-ca
UC cases
Mean age (y) 63.27  13.86
Sex
Male 185 (70.88)
Female 76 (29.12)
Educational level
Elementary school or below 106 (40.61)
High school 107 (41.00)
University or above 48 (18.39)
Alcohol consumption
Never 156 (59.77)
Frequent 59 (22.61)
Occasional 46 (17.62)
Cigarette smoking
No 120 (45.98)
Yes 141 (54.02)
Secondhand smoke exposure
No 126 (48.28)
Yes 135 (51.72)
Data are presented as n (%) or mean  standard error.
*p < 0.05.
**p < 0.001.
CI Z confidence interval; OR Z odds ratio; UC Z urothelial carcinom
a Student t test.
b c2 test.Questionnaire, interview, and biological specimen
collection
Patient demographic data and lifestyle characteristics such
as cigarette smoking, exposure to secondhand smoke, and
history of disease were collected by well-trained in-
terviewers using a structured questionnaire.24,25 A previous
study showed that urinary arsenic species were stable for at
least 6 months when preserved at e20C.26 Therefore, a 50-
mL sample of spot urine was collected for the detection of
urinary total arsenic level at the time of recruitment and
immediately stored in a e20C freezer.Determination of urinary arsenic species levels
The detailed procedures for determination of urinary
arsenic species levels have been previously described.27 A
spot urine aliquot of 200 mL was used for identification of
arsenic species by high-performance liquid chromatography
(HPLC; Waters 501; Waters Associates, Milford, MA, USA).
The contents of inorganic arsenic and its metabolites were
quantified using a hydride generator and atomic absorption
spectrometry (HG-AAS). The levels of urinary arsenic spe-
cies in standard solutions, the samples, and samples spiked
with the standard solution were detected by HPLC-HG-AAS.
Recovery rates for AsIII, DMAV, MMAV, and AsV ranged from
93.8% to 102.2%, with detection limits of 0.02 mg/L,
0.06 mg/L, 0.07 mg/L, and 0.10 mg/L, respectively. Urinary
total arsenic concentration was the sum of inorganic
arsenic (AsIII þ AsV), MMAV, and DMAV, and was normalized
against urinary creatinine levels (mg/g creatinine).ncer controls.
Controls OR (95% CI)
59.70  13.72a,** 1.02 (1.01e1.03)
438 (65.18)b 1.0
234 (34.82) 0.77 (0.57e1.06)
130 (19.35)b,** 1.00
218 (32.44) 0.53 (0.37e0.77)
324 (48.21) 0.16 (0.10e0.25)
376 (55.95)b,* 1.00
128 (19.05) 0.98 (0.66e1.44)
168 (25.00) 0.60 (0.41e0.89)
429 (63.84)b,** 1.0
243 (36.16) 2.28 (1.60e3.26)
424 (63.10)b,** 1.0
248 (36.90) 1.90 (1.42e2.55)
a.
Environmental tobacco smoke, arsenic, and UC 557Statistical analysis
Participants who had smoked >100 cigarettes during their
lifetime were regarded as ever smokers, whereas those who
had smoked <100 cigarettes were defined as never
smokers. Environmental tobacco smoke (secondhand smoke
exposure) was assessed using a questionnaire that asked
participants whether anyone had ever smoked around
them. The phrase “frequent alcohol drinker” referred to
individuals who consumed alcohol 3 days per week, and
continued this consumption for at least 6 months. Those
who consumed less than this level of alcohol were classified
as occasional drinkers. Cutoff points for specific urinary
arsenic profiles were selected using the tertile value of
controls. For the combination analysis, the cutoff point for
urinary total arsenic level (mg/g creatinine) was deter-
mined using the median of control values. The combined
effects of cigarette smoking, exposure to secondhand
smoke, and urinary total arsenic level on UC risk wereTable 2 Demographic characteristics and association with UC.
UC cases
Total arsenic (mg/g creatinine) 32.11  24.21
<11.50 36 (13.79)
11.50e20.40 55 (21.07)
20.40 170 (65.13)
As3þ 0.49  0.72
<0.053 92 (35.25)
0.053e0.654 102 (39.08)
0.654 67 (25.67)
As5þ 0.52  0.52
<0.035 2 (0.77)
0.035e0.4 135 (51.72)
0.4 124 (47.51)
MMA% 10.55  11.16
<3.04 74 (28.35)
3.05e8.87 65 (24.90)
8.87 122 (46.74)
DMA% 79.74  16.97
<84.72 144 (55.17)
84.72e92.508 66 (25.29)
92.508 51 (19.54)
InAs% 9.71  12.50
<2.61 60 (22.99)
2.61e5.70 69 (26.44)
5.70 132 (50.57)
Data are presented as n (%) or mean  standard error.
*p < 0.05.
**p < 0.01.
***p < 0.001.
CI Z confidence interval; DMA Z dimethylarsinic acid; InAs% Z (As
UC Z urothelial carcinoma.
a Student t test.estimated by odds ratios (ORs) and their 95% confidence
intervals (CIs) using a multivariate-adjusted logistic
regression formula. Potential data confounders including
age, sex, educational level, and alcohol consumption, were
adjusted in the logistic regression analysis. All data were
analyzed using SAS, version 9.2 (SAS Institute, Cary, NC,
USA). A p value <0.05 was considered statistically
significant.Results
In Table 1, a significant difference was observed in the
distribution of age (mean  standard error of the mean)
between the 261 UC patients (63.27  13.86 years) and the
672 cancer-free control individuals (56.70  13.72 years).
Individuals who had higher educational levels had a lower
risk for UC than those with a lower educational level. After
adjusting for age and sex, smokers had a significantlyControls OR (95% CI)
19.45  14.36a,*** 1.04 (1.03e1.05)
224 (33.33) 1.0
224 (33.33) 1.50 (0.95e2.39)
224 (33.33) 4.68 (3.06e7.14)
ptrend < 0.0001
0.66  1.45a,* 0.82 (0.68e1.01)
224 (33.33) 1.00
224 (33.33) 1.06 (0.75e1.49)
224 (33.33) 0.69 (0.48e1.01)
ptrend Z 0.07
0.39  0.66a,** 1.38 (1.10e1.74)
11 (1.64) 1.0
435 (64.73) 1.46 (0.32e6.73)
226 (33.63) 2.64 (0.57e12.23)
ptrend < 0.0001
7.35  6.97a,*** 1.04 (1.03e1.06)
224 (33.33) 1.0
224 (33.33) 0.87 (0.59e1.28)
224 (33.33) 1.63 (1.15e2.31)
ptrend Z 0.003
86.40  10.94a,*** 0.96 (0.95e0.98)
224 (33.33) 1.00
224 (33.33) 0.45 (0.32e0.64)
224 (33.33) 0.35 (0.24e0.51)
ptrend < 0.0001
6.25  8.19a,*** 1.04 (1.02e1.05)
224 (33.33) 1.0
224 (33.33) 1.16 (0.78e1.73)
224 (33.33) 2.29 (1.59e3.29)
ptrend < 0.0001
III þ AsV)%; MMA Z monomethylarsonic acid; OR Z odds ratio;
Figure 1 Joint effect of (A) urinary total arsenic and ciga-
rette smoking and (B) urinary total arsenic and secondhand
cigarette smoking on UC risk after multivariate adjustment for
age, gender, educational level and alcohol consumption.
Table 3 Combined effects of urinary total arsenic level,
cigarette smoking, and secondhand smoke exposure on
urothelial carcinoma risk.
Urinary total
arsenic level
(mg/g creatinine)
Cigarette
smoking
Secondhand
cigarette
exposure
OR (95% CI)a
<15.40 No No 1.00
<15.40 No Yes 1.72 (0.75e3.94)
<15.40 Yes No 2.93 (1.28e6.71)
<15.40 Yes Yes 3.00 (1.28e7.04)
15.40 No No 3.06 (1.55e6.01)
15.40 No Yes 5.55 (2.72e11.30)
15.40 Yes No 5.55 (2.67e11.54)
558 C.-C. Wu et al.increased risk for UC (OR Z 2.28, 95% CI Z 1.60  3.26)
compared to non-smokers. Individuals who were exposed to
secondhand smoke had a significantly increased risk for UC
(ORZ 1.90, 95% CIZ 1.42  2.55) compared to those who
were never exposed to secondhand smoke. Occasional
alcohol drinkers had a significantly decreased risk for UC
(OR Z 0.60, 95% CI Z 0.41  0.89) compared to non-
drinkers. However, frequent drinkers had a nonsignificant
lower risk for developing UC (ORZ 0.98) than non-drinkers.
Table 2 compares UC patients and control individuals in
terms of urinary arsenic profiles, including total arsenic
(mg/g creatinine), AsIII, AsV, MMAV%, DMAV%, and InAs (AsIII þ
AsV). UC patients had significantly higher levels of total
arsenic, AsV, MMAV%, and InAs% than control individuals. In
addition, UC patients had significantly lower levels of AsIII
and DMAV% than control individuals. Significantly increased
risks for developing UC of 4.68-, 1.63- and 2.29-fold were
found for those individuals who were exposed to higher
levels of total arsenic (20.40 mg/g creatinine), MMAV%
(8.87), and InAs% (5.70), respectively, compared to in-
dividuals who were exposed to lower levels of total arsenic
(<11.50 mg/g creatinine), MMAV% (<3.04), and InAs%
(<2.61). In addition, compared to individuals who had
lower levels of DMVA% (<84.72), significantly decreased UC
risks of 0.45- and 0.35-fold were found for those with higher
levels of DMAV% (84.72e92.508 and 92.508, respectively).
Based on the median value of urinary total arsenic levels
within the control group, we found that smokers who had
total arsenic levels of < 15.40 mg/g creatinine had a
significantly increased UC OR of 2.34, compared to never
smokers who had low levels of total arsenic (<15.40 mg/g
creatinine). In addition, significantly increased UC OR
values of 3.20 and 6.45 were also found for never smokers
with a high total arsenic level (15.40 mg/g creatinine) and
ever smokers with a high total arsenic level, respectively
(Fig. 1A). Compared to individuals who had low levels of
total arsenic and were not exposed to secondhand smoke,
significantly increased UC risks of 2.71- and 5.0-fold were
observed for those without exposure to secondhand smoke
but with a high total arsenic level, and those who were
exposed to secondhand smoke and with a high total arsenic
level, respectively (Fig. 1B).
The combined effects of cigarette smoking, exposure to
secondhand smoke, and urinary total arsenic level on the
risk of developing UC were estimated by multivariate
adjusted analysis (Table 3). Smokers who were also exposed
to secondhand smoke and had a low urinary total arsenic
level (<15.40 mg/g creatinine) had a significantly increased
risk for developing UC (3.0-fold) compared to a reference
group comprised of never smokers who had low urinary
total arsenic levels, but had not been exposed to second-
hand smoke. Furthermore, ever smokers who were exposed
to secondhand smoke and had high urinary total arsenic
levels ( 15.40 mg/g creatinine) had the greatest increased
risk for developing UC risk (10.82-fold, 95%
CI Z 5.1622.69) compared to the reference group.15.40 Yes Yes 10.82 (5.16e22.69)
ptrend < 0.0001
CI Z confidence interval; OR Z odds ratio.
a Logistic regression analysis adjusted for age, sex, educa-
tional level, and alcohol consumption.Discussion
Environmental risk factors, including chronic arsenic
exposure, cigarette smoking, and exposure to secondhand
Environmental tobacco smoke, arsenic, and UC 559smoke are major risk factors for developing UC.9 Exposure
to chemical carcinogens from cigarette smoking and
secondhand smoke can generate DNA adducts.28 A defi-
ciency in the metabolism of arsenic can induce reactive
oxygen species, which can also generate DNA adducts.28 In
the present study, ever smokers and those who were
exposed to secondhand smoke had a significantly increased
risk for developing UC, which is consistent with previous
study.11 Our findings indicated that environmental risk
factors such as cigarette smoking and exposure to second-
hand smoke have independent effects on the development
of UC.
In terms of the carcinogenic effects of different urinary
arsenic species on the risk for developing UC, a previous
study has reported a significant doseeresponse relationship
between chronic arsenic exposure and UC risk.29 Consistent
with previous findings, we observed that UC patients had
significantly higher levels of total arsenic, AsV, MMAV%, and
InAs%, as well as lower levels of AsIII and DMAV% than control
individuals.10 In the present study, a significantly increased
risk for developing UC was found for individuals who had
higher levels of urinary total arsenic, MMAV%, and InAs%.
However, a significantly decreased risk for developing UC
was found for individuals who had a high level of DMAV%. A
deficiency of arsenic methylation in humans is usually
thought to result in high MMAV percentages and low DMAV
percentages in urine. This implies that individuals who have
a weak detoxification capability may have a high risk of
developing arsenic-related malignancies.30
In addition to the significant joint effect of cigarette
smoking and urinary total arsenic levels, which has been
found in previous studies,17 we also found a significant joint
effect of exposure to secondhand smoke and urinary total
arsenic levels. Arsenic has been reported to be a constitu-
ent of tobacco smoke, therefore, exposure to secondhand
smoke may be another source of chronic arsenic expo-
sure.31,32 Moreover, a possible relationship between expo-
sure to secondhand smoke and arsenic methylation
capability on the risk for developing bladder cancer has
been reported in a previous study.18 Our findings also sug-
gest that cigarette smoking and exposure to secondhand
smoke can interact with urinary total arsenic levels.
Previous studies have reported that due to a synergistic
relationship, the combined effects of exposure to arsenic
and cigarette smoking can be much greater than the effect
of either factor alone.16,17 Compared to never smokers who
had lower total arsenic levels (< 15.40 mg/g creatinine) and
individuals who had not been exposed to secondhand
smoke, the greatest increased risk for developing UC of
10.82-fold was found for ever smokers who had higher total
urinary arsenic levels (15.40 mg/g creatinine) and had
been exposed to secondhand smoke. Furthermore, a trend
analysis revealed a progressively increasing risk for devel-
oping UC starting from no exposure to a risk factor, and
progressing to exposure to one risk factor, and exposure to
two or all three risk factors (data not shown).
The present study had some limitations. First, the ac-
curacy of determining urinary arsenic species by using a
single spot of urine may be limited; however, the levels
were stable if individuals had not recently changed their
lifestyle. Second, due to the small sample size, the statis-
tical significance of the results should be interpreted withcaution. Third, records concerning exposure to other
chemicals such as combustion gases, soot from coal,
chemical dyes, and certain Chinese herbs that may be may
be associated with UC were unavailable for this study. In
addition, in the future, polymorphic forms of candidate
genes that may be involved in the biotransformation of
arsenic should be taken into consideration when exploring
genetic effects on the risk for developing UC.
In conclusion, a Taiwanese population who smoked cig-
arettes, were exposed to secondhand smoke, and had a
high urinary total arsenic level, showed a significantly
increased risk for developing UC, even in the absence of
obvious exposure to arsenic.Acknowledgments
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